Skip to content

Biohaven BHVN Common Stock Shares Issued

Common Stock Shares Issued at other companies

Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
161.2M+16.8%
ADMA Biologics logo
ADMA BiologicsADMA
241M+27,715%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
103.4M+35.6%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
102.5M+25.6%
Roivant Sciences logo
Roivant SciencesROIV
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.23B-48.1%
Enterprise value$2.23B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's common stock shares issued?
Biohaven (BHVN) reported common stock shares issued of 150.5M in Q1 2026.
How has Biohaven's common stock shares issued changed year-over-year?
Biohaven's common stock shares issued increased by 47.4% year-over-year, from 102.1M to 150.5M.
What is the long-term trend for Biohaven's common stock shares issued?
Over 3 years (2022 to 2025), Biohaven's common stock shares issued has grown at a 24.9% compound annual growth rate (CAGR), from 68.2M to 132.8M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.